The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Cost Plus, Inc. In Connection With The Sale Of The Company To Bed Bath & Beyond Inc.

Levi & Korsinsky is investigating the Board of Directors of Cost Plus, Inc. (“Cost Plus” or the “Company”) (Nasdaq: CPWM) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bed Bath & Beyond Inc. (Nasdaq: BBBY). Under the terms of the transaction, Cost Plus shareholders will receive $22.00 for each share of Cost Plus stock they own. The transaction has a total approximate value of $494 million. Shareholders owning a combined 25% of the Company’s outstanding shares have agreed to tender their shares.

Click here to learn how to join the action:, or call: 877-363-5972. There is no cost or obligation to you.

The investigation concerns whether the Cost Plus Board of Directors breached their fiduciary duties to Cost Plus stockholders by failing to adequately shop the Company before entering into this transaction and whether Bed Bath & Beyond Inc. is underpaying for Cost Plus shares, thus unlawfully harming Cost Plus stockholders.

If you own common stock in Cost Plus and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or

Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

If you liked this article you might like

Cramer's 'Mad Money' Recap: Now, the Focus Is Earnings

Investors Shun Bed Bath & Beyond, Walgreens Growth Deals

Cost Plus Stock Hits New 52-Week High (CPWM)

Bed Bath & Beyond Deal Shows Right Kind of Risk Taking

5 Stocks Hit 52-Week Highs: Cost Plus, News Corp